EU agency recommends extended approval of Roche's Actemra

04/26/2010 | Reuters

Roche Holding said the European Medicines Agency recommended extended approval of Actemra, an anti-interleukin-6 receptor antibody, for use in combination with standard treatment methotrexate in patients with rheumatoid arthritis. The company received the recommendation after providing the EU agency with two years of clinical data.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA